Neuprex rBPI-21 bactericidal/permeability increasing protein: Began a Phase II efficacy trial in 400 patients who have received at least two units of blood with

The study will enroll patients whose onset of trauma

Read the full 90 word article

How to gain access

Continue reading with a
two-week free trial.